The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence

Size: px
Start display at page:

Download "The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence"

Transcription

1 The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary University of London

2 Cancer, rare disease, infection Genomics England Mission Sequence 100,000 whole genomes Capture data delivered electronically, store it securely and analyse it within an English data centre (reading library) Genomes with electronic clinical information for longitudinal life course analysis, interpretation, and aggregation Transform the NHS capacity, capability and leave a legacy in personalised medicine to generate health and wealth for the UK 1. To bring benefit to NHS patients 3. To create an ethical and transparent programme based on consent 2. To enable new scientific discovery and medical insights 4. To kickstart the development of a UK genomics industry

3 The 100,000 Genomes Project 04 November

4 Genomics England The Big Data Potential 13 NHS Genomic Medicine Centres Rare diseases, cancers and pathogens Broad consent, characteristics, molecular pathology and samples NIHR Biosample Centre DNA & multi-omics Repository Sequencing Centre Wellcome Trust 27m Illumina Partnership Refreshable identifiable Clinical Data Life-course registry Linked to anonymised Whole Genome Sequence Oxford Big Data NHS Digital Primary Care Hospital episodes Cancer Registries Rare Registries Infectious Disease Mortality data Patient entry Fire wall Patient data stays in safe haven MRC 24m Research Data Infrastructure Sequential builds of pseudonymised data and WGS Safe haven- Reading library Annotation & QC SME Product comparison Only processed results pass outside Clinicians & Academics 25m in Training 700 person years Industry GENE Consortium

5 New Sequencing Centre at Hinxton US genomics giant Illumina building new European HQ in Cambridge jobs 60 M

6 Rare Inherited diseases 5000 people in the pilot 18,000 in the main programme <5% of the population 7000 rare diseases 150/200 disorders Detailed standardised eligibility & characterisation Prior genetic testing usual care Human Phenotyping Ontology Disease progression WGS 30X

7 Newborn with severe immunodeficiency Closely related parents New born in ITU from birth Recurrent infections Fluctuating neurology Unexplained lots of tests Child died at 4 months with no diagnosis Parents and deceased child join the 100,000 Genomes Project at their request Mum becomes pregnant and declines all testing but at 8 months becomes anxious Mutation identified, NHS validate it, fed back

8 Sequencing cancer genomes The diagnostic and the genomic biopsy Cancer programme Gear 1- mainstream supply of fresh frozen tissue Gear 2- small studies Gear 3- trials Cancer is challenging Transforming molecular pathology High calibre genomes Actionable 25-40% of the time Working on lung, breast, colon, prostate, ovary, sarcoma, renal, haematological oncology Adopting bladder, brain, testis, childhood cancer, unknown primary

9 Infections and Pathogens 3000 Multi-drug resistance TB strains NHS implementing TB sequencing for diagnosis Global registry of TB resistance

10 Genomics England Clinical Interpretation Partnership Matina Prapa, Simon Thompson and Kate Witowska

11 Why do we need a Clinical Interpretation Partnership? The standard way The GeCIP way Start yrs?3 yrs Securing Patient Benefit

12 Information about a patient s main condition What are we telling Information about additional serious and actionable conditions (optional) participants? Carrier status for non affected parents of children with rare disease (optional) Image courtesy of Health Education England 04 November

13 Industry Consortium and Partners 12 pharma/diagnostics/smes Precompetitive consortia Work together on 5000 WGS to shape data centre Individual company interactions Inward investment from Illumina 50m in new HQ in Cambridge AbbVie Alexion Pharmaceuticals AstraZeneca Biogen Dimension Therapeutics GSK Helomics Roche Takeda Berg Boehringer Ingelheim UCB

14 International Country Description Status Details of joint working Canada Australia Genome British Columbia/ Canada Garvan Institute Australian Genomes MoU signed MoU signed Estonia Central biobank Meeting held Denmark Norway 5 regional health sectors & central biobank National hub & spoke model Meeting held & visit undertaken Meetings held Partnership projects under consideration GMC Data Visualisation Intellectual disability Potential for national collaboration France INSERM & Genopole Meetings held 600m Euros Singapore National initiative Meeting held Some funds Japan National Initiative Multiple meetings held Circa 70m programme

15 Building the future of genomic medicine 100,000 WGS on NHS patients and pathogens Concentrating the UK Genomics Knowledgebase in one location The NHS, academics and industry partnerships at the outset to drive Genomic Medicine into the NHS and create wealth Building the human capacity and capability Key international partnerships to add value Leave a legacy of NGS Centres, sample pipeline and biorepository, large-scale data store that makes this usable by the NHS New diagnostics and therapies and opportunities for patients

16 More information and jobs =twsrc%5etfw

Genomics and personalised medicine

Genomics and personalised medicine Genomics and personalised medicine Dr Tom Fowler, Deputy Chief Scientist & Director of Public Health WHO Symposium on the Future of Digital Health Systems in the European Region February 2019 About me

More information

The 100,000 Genomes Project

The 100,000 Genomes Project The 100,000 Genomes Project Dr Tom Fowler, Deputy Chief Scientist Genomics England Jillian Hastings Ward, Chair, National 100K Participant Panel The Kings Fund, 6th October 2017 Our Mission 100,000 whole

More information

The 100,000 Genomes Project Rare Disease Programme

The 100,000 Genomes Project Rare Disease Programme The 100,000 Genomes Project Rare Disease Programme Dr Richard Scott Clinical Lead for Rare Disease, Genomics England Consultant in Clinical Genetics, Great Ormond Street The 100,000 Genomes Project History

More information

The 100,000 Genomes Project

The 100,000 Genomes Project The 100,000 Genomes Project Louise J Jones Genomics England James Fisher Director, Genomics Implementation Unit North East & North Cumbria Cancer Alliance Launch Event 30 th March 2017 The first human

More information

Genomics in the NHS. Professor Sue Chief Scientific Officer for England

Genomics in the NHS. Professor Sue Chief Scientific Officer for England Genomics in the NHS Professor Sue Hill @CSOSue Chief Scientific Officer for England Nov 2017 100,000 Genomes Project: overview PRINCIPLES 100,000 genomes from Rare Disease (families) & Cancer (people &

More information

NHS ENGLAND BOARD PAPER

NHS ENGLAND BOARD PAPER NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce

More information

Delivering Genomic Medicine at a Population Level: beyond the 100,000 Genomes Project

Delivering Genomic Medicine at a Population Level: beyond the 100,000 Genomes Project Delivering Genomic Medicine at a Population Level: beyond the 100,000 Genomes Project J Louise Jones Barts Cancer Institute Barts Health NHS Trust Genomics England What is Genomic Medicine? an emerging

More information

BOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy.

BOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy. Paper: PB.24.09.15/05 Title: Personalised Medicine Strategy. From: Sir Bruce Keogh, National Medical Director. BOARD PAPER - NHS ENGLAND Purpose of Paper: To inform the Board of the development of an NHS

More information

Genomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service

Genomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service Genomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service Professor Dame Sue Hill @CSOsue Chief Scientific Officer for England SRO Genomics, NHS England September 2018 Genomics:

More information

Scottish Genomes Project: Taking Genomics into Healthcare. Zosia Miedzybrodzka

Scottish Genomes Project: Taking Genomics into Healthcare. Zosia Miedzybrodzka Scottish Genomes Project: Taking Genomics into Healthcare Zosia Miedzybrodzka DNA GENOME IS ALL OF OUR DNA: CODING & NON-CODING Sequencing of Whole Genomes at Scale in Scotland Edinburgh Genomics Sequencing

More information

1.0 Background to the organisation

1.0 Background to the organisation 1.0 Background to the organisation The National University of Ireland Galway, the Royal College of Surgeons in Ireland, University College Cork, University College Dublin and Trinity College and their

More information

Genomic Strategy for Scotland. ACGS Meeting 29 th June 2018

Genomic Strategy for Scotland. ACGS Meeting 29 th June 2018 Genomic Strategy for Scotland ACGS Meeting 29 th June 2018 The current landscape Advances in genomics and informatics are driving a better understanding of the molecular basis of disease. Rapid advancement

More information

The NIHR. NIHR: health research in Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London. Clinical Research Network

The NIHR. NIHR: health research in Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London. Clinical Research Network The NIHR NIHR: health research in 2030 Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London Why? https://www.bhf.org.uk/publications/statistics/ trends-in-coronary-heart-disease-1961-2011

More information

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.

More information

100,000 Genomes Project Rare Disease Programme. Dr Richard Scott Clinical Lead for Rare Disease, Genomics England

100,000 Genomes Project Rare Disease Programme. Dr Richard Scott Clinical Lead for Rare Disease, Genomics England 100,000 Genomes Project Rare Disease Programme Dr Richard Scott Clinical Lead for Rare Disease, Genomics England Recruitment to 16 th June 31,231 rare disease participants Average = 490 participants /

More information

Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015

Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015 Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015 Dr. I.J. Nijman Disclosure slide (Potential) conflict of interest None For this meeting relevant

More information

Interpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI

Interpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI Interpreting Genome Data for Personalised Medicine Professor Dame Janet Thornton EMBL-EBI Deciphering a genome 3 billion bases 4 million variants 21,000 coding variants 10,000 non-synonymous variants 50-100

More information

Molecular Diagnostics

Molecular Diagnostics Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

More information

Creating a national Genomic Medicine Service. Professor Sue Chief Scientific Officer for England

Creating a national Genomic Medicine Service. Professor Sue Chief Scientific Officer for England Creating a national Genomic Medicine Service Professor Sue Hill @CSOsue Chief Scientific Officer for England Jun 2017 Into the next generation science moving beyond genomics alone DNA HGP 100,000 Genomes

More information

Roche in Australia Innovation Leader

Roche in Australia Innovation Leader Roche in Australia Innovation Leader About Roche Innovation: it s in our DNA 7,000,874 hours of work 6,587 experiments 423 researchers 1 drug For nearly 120 years, Roche has been committed to improving

More information

A whole-system approach to delivering personalised medicine and health in Leeds. Mike Messenger

A whole-system approach to delivering personalised medicine and health in Leeds. Mike Messenger A whole-system approach to delivering personalised medicine and health in Leeds Mike Messenger Capacity and Resource What is the challenge? In 2016, we face the most significant challenges for a generation.

More information

Implementing a National Genomic Medicine Service for the NHS: building on the legacy of the 100,000 Genomes Project

Implementing a National Genomic Medicine Service for the NHS: building on the legacy of the 100,000 Genomes Project Implementing a National Genomic Medicine Service for the NHS: building on the legacy of the 100,000 Genomes Project A joint event by the All-Party Parliamentary Health Group and the All- Party Parliamentary

More information

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response

More information

IRDiRC: International Rare Diseases Research Consortium

IRDiRC: International Rare Diseases Research Consortium IRDiRC: International Rare Diseases Research Consortium EuRenomics, NEUROMICS and RD-Connect Joint Kick-off Meeting Sitges, Spain, 25 January 2013 Dr. Iiro Eerola Scientific Project Officer Unit for Personalised

More information

2018/2019 final draft National Genomic Test Directory FAQ

2018/2019 final draft National Genomic Test Directory FAQ 2018/2019 final draft National Genomic Test Directory FAQ August 2018 1 Contents 1 Introduction... 3 2 About the Test Directory... 3 3 Frequently asked questions... 4 3.1 Where has the Test Directory been

More information

Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre

Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Bryan Williams MD FRCP FESC FAHA Professor of Medicine and BRC Director 29/08/2013 Creating

More information

Delivering on the Promise of Precision Medicine

Delivering on the Promise of Precision Medicine Delivering on the Promise of Precision Medicine Bay Area Council Economic Institute Spring 2016 The Promise of Precision Medicine The Bay Area is one of the world s biggest hubs for innovation in research

More information

Delivering the NIHR Central Commissioning Facility

Delivering the NIHR Central Commissioning Facility Delivering the NIHR Central Commissioning Facility About the NIHR The National Institute for Health Research is funded through the Department of Health to improve the health and wealth of the nation through

More information

TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS. H a n n s Lochmüller, Newcastle University

TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS. H a n n s Lochmüller, Newcastle University TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS H a n n s Lochmüller, Newcastle University Addressing the translational pathway 2 Trials Gene identification/ pathophysiology

More information

Personalized. Health in Canada

Personalized. Health in Canada Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute

More information

7/21/2017. Transforming the histopathology workforce: perspectives from the Genomics Education Programme

7/21/2017. Transforming the histopathology workforce: perspectives from the Genomics Education Programme Transforming the histopathology workforce: perspectives from the Genomics Education Programme Dr Anneke Seller, Scientific Director, HEE Genomics Education Programme 100,000 Genomes: Cornerstone of future

More information

Research and innovation at the heart of the NHS Sir Malcolm Grant, Chair, NHSE

Research and innovation at the heart of the NHS Sir Malcolm Grant, Chair, NHSE Research and innovation at the heart of the NHS Sir Malcolm Grant, Chair, NHSE NHS Health and Care Innovation Expo 6 September 2018 What this session is about The economic case The opportunity: research

More information

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine Nordic Common Strengths and Future Potential in the Field of Personalised Medicine NOS-M Workshop 23rd November 2016 Stockholm Waterfront Johan Nilsson Coordinator Medicine and Health Swedish Research

More information

THE WHITE HOUSE Office of the Vice President

THE WHITE HOUSE Office of the Vice President FOR IMMEDIATE RELEASE October 17, 2016 THE WHITE HOUSE Office of the Vice President FACT SHEET: Vice President Biden Delivers Cancer Moonshot Report, Announces Public and Private Sector Actions to Advance

More information

Biobanking for the 100,000 genomes project. BBMRI-UKCTC satellite meeting 29 th September

Biobanking for the 100,000 genomes project. BBMRI-UKCTC satellite meeting 29 th September Biobanking for the 100,000 genomes project BBMRI-UKCTC satellite meeting 29 th September The challenge Scale Quality Patient to sample/data to clinician Impact of pre-analytical variables vs cost of process

More information

The HUNT Study and potential for innovation and industry research collaboration

The HUNT Study and potential for innovation and industry research collaboration 1 The HUNT Study and potential for innovation and industry research collaboration Professor Kristian Hveem, MD, PhD, Director of HUNT biobank, NTNU Head of Biobank Norway (BBMRI.no) Head of K.G. Jensen

More information

BIOMEDICAL RESEARCH CENTRES

BIOMEDICAL RESEARCH CENTRES Introduction BIOMEDICAL RESEARCH CENTRES The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the

More information

TRANSLATIONAL RESEARCH PARTNERSHIPS

TRANSLATIONAL RESEARCH PARTNERSHIPS TRANSLATIONAL RESEARCH PARTNERSHIPS Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. NIHR Translational Research

More information

NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE

NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE EXPERTISE AND CAPABILITIES The TRC in Inflammatory Respiratory Disease provides cutting-edge expertise in the development of exploratory

More information

Research and development case study. Human health research

Research and development case study. Human health research Research and development case study Human health research November 2017 Introduction This case study on human health research is one of a series that we have developed to support and complement our published

More information

MRC Stratified Medicine Initiative

MRC Stratified Medicine Initiative MRC Stratified Medicine Initiative Jonathan Pearce Medical Research Council, Translational Programme Manager Pharmacogenetics and Stratified Medicine Network Conference : 14 th January 2015 Stratified

More information

Supporting efficient and effective clinical research in the UK

Supporting efficient and effective clinical research in the UK Supporting efficient and effective clinical research in the UK National Institute for Health Research 10 years of delivering health and care research for the nation HRB CRCI Launch Dr Matthew Hallsworth

More information

Data Mining for Genomic- Phenomic Correlations

Data Mining for Genomic- Phenomic Correlations Data Mining for Genomic- Phenomic Correlations Joyce C. Niland, Ph.D. Associate Director & Chair, Information Sciences Rebecca Nelson, Ph.D. Lead, Data Mining Section City of Hope National Medical Center

More information

Using Human Tissue in Translational Research and Clinical Trials

Using Human Tissue in Translational Research and Clinical Trials Using Human Tissue in Translational Research and Clinical Trials Dr Bridget S Wilkins NCRI Clinical Lead for Pathology Engagement (Consultant Histopathologist, St Thomas Hospital, London) Cellular and

More information

The Curative and Transformative Potential of Novel Therapies for Rare Diseases in the Age of Precision Medicine

The Curative and Transformative Potential of Novel Therapies for Rare Diseases in the Age of Precision Medicine The Curative and Transformative Potential of Novel Therapies for Rare Diseases in the Age of Precision Medicine Christopher P. Austin, M.D. Director, NCATS/NIH EveryLife Scientific Workshop September 12,

More information

Genomics for Precision Medicine Strategy

Genomics for Precision Medicine Strategy Genomics for Precision Medicine Strategy July 2017 Mae r ddogfen yma hefyd ar gael yn Gymraeg. This document is also available in Welsh. Crown Copyright WG 32505 Genomics for Precision Medicine Strategy

More information

Unlocking the Power of the Genome

Unlocking the Power of the Genome Unlocking the Power of the Genome Sam Samad, Chief Financial Officer William Blair Growth Stock Conference, 13 June 2018 2018 Illumina, Inc. All rights reserved. Safe Harbor Statement This presentation

More information

Rare Diseases: Challenges and Opportunities NIH Perspective

Rare Diseases: Challenges and Opportunities NIH Perspective Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes

More information

The Innovative Medicines Initiative. Pierre Meulien CNIO, Madrid - Spain

The Innovative Medicines Initiative. Pierre Meulien CNIO, Madrid - Spain The Innovative Medicines Initiative Pierre Meulien 12.01.2017 CNIO, Madrid - Spain IMI Europe s partnership for health > 5 bn 2.5 bn Partnership 2008-2020 Pharma industry 2.5 bn EU contribution from FP7

More information

ADVANCE MEDICINE. AstraZeneca Japan President Stefan Woxström shares his healthcare vision. By C Bryan Jones

ADVANCE MEDICINE. AstraZeneca Japan President Stefan Woxström shares his healthcare vision. By C Bryan Jones ADVANCE MEDICINE AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With

More information

Overview: Towards a European open source knowledge management infrastructure. Scott Wagers, MD BioSci Consulting

Overview: Towards a European open source knowledge management infrastructure. Scott Wagers, MD BioSci Consulting Overview: Towards a European open source knowledge management infrastructure Scott Wagers, MD BioSci Consulting Innovative Medicines Initiative: Joining Forces in the Healthcare Sector U-BIOPRED Annual

More information

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER

More information

Improved analysis of genetic testing could lead to more patients with inherited conditions being successfully diagnosed

Improved analysis of genetic testing could lead to more patients with inherited conditions being successfully diagnosed PRESS RELEASE 17 August 2016 Improved analysis of genetic testing could lead to more patients with inherited conditions being successfully diagnosed A groundbreaking study, led by experts from Royal Brompton

More information

What does Big Pharma want?

What does Big Pharma want? Tissue banking in the NHS - the advantages for Pathology Departments What does Big Pharma want? Why do we want it? How do we get it? Chris Womack Principal Clinical Histopathologist Oncology Early Drug

More information

EU Big Data Initiatives

EU Big Data Initiatives European Network of Excellence for Big Data in Hematology, consisting of 51 partners from 11 countries. Aliki Taylor, HARMONY Alliance Partner Director Global Health Outcomes, Takeda EU Big Data Initiatives

More information

LEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE

LEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE LEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE LEEDS CITY REGION S STRENGTHS: LIFE SCIENCES - THE OPPORTUNITY TAP INTO WORLD-LEADING RESEARCH FROM LEEDS CITY REGION S UNIVERSITIES ACCELERATING

More information

PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS

PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS CLEAR DIAGNOSIS TARGETED TREATMENT STRENGTHENED RESEARCH SUMMARY NATIONAL STRATEGY FOR PERSONALISED MEDICINE 2017-2020 FOREWORD Personalised Medicine

More information

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University Vision, aims and strategies Department of Immunology, Genetics and Pathology Uppsala University April19,2011 SCOPEOFACTIVITIESATIGP Research at the Department focuses on translational medicine through

More information

Clinical Trial Research in the Precision Medicine Era: the Manchester City Approach

Clinical Trial Research in the Precision Medicine Era: the Manchester City Approach 1 Clinical Trial Research in the Precision Medicine Era: the Manchester City Approach JACK LONDON, PHD RESEARCH PROFESSOR OF CANCER BIOLOGY THOMAS JEFFERSON UNIVERSITY DIRECTOR OF INFORMATICS SIDNEY KIMMEL

More information

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 Submitted resources from physician organization representatives were mapped

More information

- OMICS IN PERSONALISED MEDICINE

- OMICS IN PERSONALISED MEDICINE SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary

More information

ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure

ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure Marialuisa Lavitrano Università Milano-Bicocca Coordinatore BBMRI-Italia

More information

Ethics of Precision Medicine in Low to Middle Income Countries

Ethics of Precision Medicine in Low to Middle Income Countries Ethics of Precision Medicine in Low to Middle Income Countries Sola Olopade, MD, MPH Professor of Medicine Director, International Programs Faculty, MacLean Center for Clinical Ethics University of Chicago

More information

Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017

Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017 New Tools for Personalized Medicine *Tools = Assays, Devices, Software Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017 http://epigenomics.cemm.oeaw.ac.at http://biomedical-sequencing.at

More information

University of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine

University of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine University of Athens - Medical School pmedgr The Greek Research Infrastructure for Personalized Medicine - George Kollias - Professor of Experimental Physiology, Medical School, University of Athens President

More information

The Innovative Medicines Initiative: Building new models of collaborative research across Europe

The Innovative Medicines Initiative: Building new models of collaborative research across Europe The Innovative Medicines Initiative: Building new models of collaborative research across Europe Elisabetta Vaudano IMI, Belgium www.imi.europa.eu What is IMI? An European Public-Private Partnership Focused

More information

Translational Research

Translational Research Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic

More information

Interview. Maximizing the Value of Biospecimens to Deliver New Therapies. with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca

Interview. Maximizing the Value of Biospecimens to Deliver New Therapies. with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca Interview Maximizing the Value of Biospecimens to Deliver New Therapies with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca Introduction and Background CLIVE GREEN This ebook originated

More information

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap

More information

Stratified Medicine in the UK

Stratified Medicine in the UK Technology Strategy Board Driving Innovation Stratified Medicine in the UK Vision and Roadmap Stratified Medicine in the UK Stratified Medicine in the UK Vision and Roadmap Summary A consortium of government

More information

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results

More information

Innovative Medicines Initiative

Innovative Medicines Initiative Innovative Medicines Initiative EMA - EBE Regulatory Conference on ATMPs Salah-Dine Chibout, Novartis Global Head Discovery & Investigative Safety/ Global Head Preclinical Safety Therapeutic Areas IMI

More information

NIHR Cambridge Clinical Research Facility

NIHR Cambridge Clinical Research Facility NIHR Cambridge Clinical Research Facility National Institute for Health Research The perfect environment for experimental medicine studies and early phase clinical trials for Life Sciences, Biotech and

More information

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you

More information

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS 1. Introduction 1.1 This document provides guidance notes for the assessment of academic qualifications that have not been formally accredited

More information

Finnish Biobanks. The most advanced testbed in the world

Finnish Biobanks. The most advanced testbed in the world Finnish Biobanks The most advanced testbed in the world Jaana Hartikainen, Ph.D., Adjunct Professor in Molecular Genetics Assistant Professor in Translational Cancer Research and Biobank Research University

More information

Genomics and Healthcare A global and local perspective

Genomics and Healthcare A global and local perspective Genomics and Healthcare A global and local perspective Kathryn North Director, Murdoch Childrens Research Institute Director, Victorian Clinical Genetics Service David Danks Professor of Child Health Research,

More information

Nanthealth Patient Informed Consent

Nanthealth Patient Informed Consent Patient Informed Consent Why am I being asked to give consent? You are being asked to sign this consent form because you want to have a molecular/genomic analysis performed to help your physician understand

More information

The experience of Andalusia in ehealth and big data --- Big data in health - IMI s HARMONY project, European Parliament, Brussels, 19 June 2018

The experience of Andalusia in ehealth and big data --- Big data in health - IMI s HARMONY project, European Parliament, Brussels, 19 June 2018 The experience of Andalusia in ehealth and big data --- Big data in health - IMI s HARMONY project, European Parliament, Brussels, 19 June 2018 Joaquín Dopazo Área de Bioinformática, Fundación Progreso

More information

Leveraging an Academic-Industry Partnership for Commercial Success

Leveraging an Academic-Industry Partnership for Commercial Success Leveraging an Academic-Industry Partnership for Commercial Success For 115 Years, the Nation s Leading Respiratory Hospital Respiratory Heritage: 115 Years of Respiratory Research and Care Allergy, Asthma,

More information

NATURE AND NURTURE: BABY S DEVELOPMENT IS AFFECTED BY GENES AND CONDITIONS IN THE WOMB

NATURE AND NURTURE: BABY S DEVELOPMENT IS AFFECTED BY GENES AND CONDITIONS IN THE WOMB MEDIA RELEASE 28 APRIL 2014 NATURE AND NURTURE: BABY S DEVELOPMENT IS AFFECTED BY GENES AND CONDITIONS IN THE WOMB A*STAR-led international study provides new insights into the relationship between genes

More information

Transforming care for the future

Transforming care for the future Transforming care for the future Professor Sue Hill @CSOSue Chief Scientific Officer for England Date 2017 The National Health Service (NHS) in numbers Semi-integrated system providing care to 55 million

More information

Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis

Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis -Collaboration to explore use of mrna Therapeutics to treat the underlying cause of CF

More information

23andMe Research: By the People, For the People. Carrie Northover, PhD Manager, Research Partnerships Health Datapalooza 2016

23andMe Research: By the People, For the People. Carrie Northover, PhD Manager, Research Partnerships Health Datapalooza 2016 23andMe Research: By the People, For the People Carrie Northover, PhD Manager, Research Partnerships Health Datapalooza 2016 What is 23andMe? Direct to consumer genetic testing company Customers receive

More information

6th Form Open Day 15th July 2015

6th Form Open Day 15th July 2015 6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine

More information

BIOTECH IN FRANCE. key info in. points

BIOTECH IN FRANCE. key info in. points BIOTECH IN FRANCE 10 key info in points 1 2 3 INSERM: EUROPE S #1 ACADEMIC BIOTECH RESEARCH INSTITUTE INSERM spearheads healthcare and medical research in France, filing more biotech patents with the European

More information

-YOUR PARTNER IN RESEARCH AND DEVELOPMENT

-YOUR PARTNER IN RESEARCH AND DEVELOPMENT -YOUR PARTNER IN RESEARCH AND DEVELOPMENT WHY CHOOSE NORWAY? A healthcare system with great opportunities for research....... 2 Unique and accessible health registries and biobanks........... 3 A great

More information

Improving Population Health One Person at a Time

Improving Population Health One Person at a Time Improving Population Health One Person at a Time Session #PH5, March 5, 2018 India Hook-Barnard, PhD Director, Research Strategy Associate Director, Precision Medicine 1 Conflict of Interest India Hook-Barnard,

More information

2017 HTS-CSRS COMMUNITY PUBLIC WORKSHOP

2017 HTS-CSRS COMMUNITY PUBLIC WORKSHOP 2017 HTS-CSRS COMMUNITY PUBLIC WORKSHOP GenomeNext Overview Olympus Platform The Olympus Platform provides a continuous workflow and data management solution from the sequencing instrument through analysis,

More information

Personalized Human Genome Sequencing

Personalized Human Genome Sequencing Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome

More information

Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare

Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare The world of healthcare is changing - with two revolutionary technologies, genomics and blockchain poised to significantly

More information

Willem H Ouwehand FMedSci Professor of Experimental Haematology Director NIHR BioResource Rare Diseases

Willem H Ouwehand FMedSci Professor of Experimental Haematology Director NIHR BioResource Rare Diseases Willem H Ouwehand FMedSci Professor of Experimental Haematology Director NIHR BioResource Rare Diseases Did The Cambridge genomic revolution discoveries when and how will it impact on the NHS and thus

More information

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International

More information

The Wellcome Trust. Research Support and Strategy in Epidemiology. Monday, 22 September Dr Alan Doyle

The Wellcome Trust. Research Support and Strategy in Epidemiology. Monday, 22 September Dr Alan Doyle The Wellcome Trust Research Support and Strategy in Epidemiology Monday, 22 September 2008 Dr Alan Doyle The Wellcome Trust an independent researchfunding charity established 1936 funded from private endowment

More information

BREXIT BRIEFING. Medical research. Maintaining an effective working relationship between the UK and the EU. British Medical Association bma.org.

BREXIT BRIEFING. Medical research. Maintaining an effective working relationship between the UK and the EU. British Medical Association bma.org. BREXIT BRIEFING Medical research Maintaining an effective working relationship between the UK and the EU British Medical Association bma.org.uk 2 British Medical Association Medical research Key points

More information

Data Warehouse Systems at the German Centers for Health Research (DZG)

Data Warehouse Systems at the German Centers for Health Research (DZG) Data Warehouse Systems at the German Centers for Health Research (DZG) Roland Eils 26.10.16 Roland Eils The German Centers for Health Research è Fighting major disease challenges è Translational Research,

More information

Biomarkers as an emerging growth area in Denmark

Biomarkers as an emerging growth area in Denmark Biomarkers as an emerging growth area in Denmark International Conference on Perspectives in Precision Medicine, Copenhagen March 1, 2018 Kim Holmstrøm, PhD. Chairman of The Danish Biomarker Network R&D

More information

Dr. Stephen Kingsmore a vision for transforming medicine with rapid genome sequencing

Dr. Stephen Kingsmore a vision for transforming medicine with rapid genome sequencing Dr. Stephen Kingsmore a vision for transforming medicine with rapid genome sequencing Dr. Stephen Kingsmore, MD, DSc, is the President and CEO of the Rady Pediatric Genomics and Systems Medicine Institute.

More information

NIHR at 10: Wessex. Professor Chris Whitty Chief Scientific Adviser Department of Health

NIHR at 10: Wessex. Professor Chris Whitty Chief Scientific Adviser Department of Health NIHR at 10: Wessex Professor Chris Whitty Chief Scientific Adviser Department of Health Building on 10 remarkable years The extraordinary advances in health are based on evidence and science, properly

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISEASE/CONDITION POPULATION TRIAD Submitting laboratory: Cambridge RGC Approved: September 2012

More information